Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
- PMID: 28446562
- DOI: 10.1183/13993003.00317-2017
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis
Conflict of interest statement
Conflict of interest: None declared.
Comment on
-
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.Eur Respir J. 2017 Mar 22;49(3):1602308. doi: 10.1183/13993003.02308-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28331043 Free PMC article.
-
Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis.Eur Respir J. 2017 Apr 26;49(4):1700173. doi: 10.1183/13993003.00173-2017. Print 2017 Apr. Eur Respir J. 2017. PMID: 28446561 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources